Methylxanthine drugs are human pancreatic lipase inhibitors

• Autorzy: Wikiera A. , Mika M. , Zyla K.
• Języki publikacji: EN

Abstrakty

EN

Methylxanthines such as caffeine, theobromine and theophylline are intensively consumed as food components by large proportion of human population all over the world. This class of compounds show various biological activities and have been found to act as broad specifi city inhibitors towards numerous enzymes. However, their action on digestive enzymes have not been yet investigated. In this paper we aimed to evaluate the effects of methylxanthines on the human pancreatic lipase activity in vitro. Emulsions of short- and long-chain triglycerides (tributyrin and tripalmitate, respectively) were used as substrates. The concentrations of methylxanthines in the reaction mixtures covered the range between 0.015 mmol/L to 15 mmol/L. We demonstrated that all three tested substances, caffeine, theophylline and theobromine inhibited the hydrolysis of tributyrin and tripalmitate catalysed by human pancreatic lipase in dose-dependent fashion. The highest lipase inhibition ratios during tripalmitate and tributyrin hydrolysis were 25.74% and 79.54% respectively in the presence of caffeine, 29.89% and 62.79% respectively with theophylline and 21.08% and 67.74% respectively in the presence of theobromine. All the tested methylxanthines exert stronger inhibition in the short-chain triglyceride lipolysis comparing to long-chain substrates. Their mechanism of action involves most likely the interaction with enzyme protein but not substrate emulgation. In case of tripalmitate lipolysis all the methylxanthines showed mixed type of inhibition. Interestingly, during tributyrin lipolysis theophylline behaved as classical noncompetitive inhibitor.

• Wydawca: -
• Czasopismo: Polish Journal of Food and Nutrition Sciences
• Rocznik: 2012
• Tom: 62
• Numer: 2
• Opis fizyczny: p.109-113,fig.,ref.

Twórcy

autor

Wikiera A.

• Department of Food Biotechnology, Faculty of Food Technology, Agricultural University of Krakow, Balicka 122, 31-149 Krakow, Poland

autor

Mika M.

autor

Zyla K.

Bibliografia

• 1. Baselt R.C., Disposition of Toxic Drugs and Chemicals in Man. 2004, 7th ed. Biomedical Publications. Foster City, CA, pp. 157––159.
• 2. Brockman H.L., Kinetic behaviour of the pancreatic lipase-colipase-lipid system. Biochimie, 2000, 82, 987–995.
• 3. Caudle A.G., Bell L.N., Caffeine and theobromine contents of ready-to-eat chocolate cereals. Research and Professional Briefs, J. Am. Diet. Assoc., 2000, 100, 690–692.
• 4. Colin D.Y., Deprez-Beauclair P., Allouche M., Brasseur R., Kerfelec B., Exploring the activity site cavity of human pancreatic lipase. Biochem. Biophys. Res. Commun., 2008, 370, 394–398.
• 5. Eteng M.U., Ettarh R.R., Comparative effects of theobromine and cocoa extract on lipid profi le in rats. Nutr. Res., 2000, 20, 1513–1517.
• 6. Fish B.C., Thompson L.U., Lectin-tanin interactions and infl uence on pancreatic amylase activity and starch digestibility. J. Agric. Food Chem., 1991, 39, 727–731.
• 7. Freie A.B., Ferrato F., Carriare F., Lowe M.E., Val-407 and Ile- -408 in the beta 5’-loop of pancreatic lipase mediate lipase-colipase interactions in the presence of bile salt micelles. J. Biol. Chem., 2006, 281, 7793–7800.
• 8. Greenway F.K. de Jonge L., Blanchard D., Frisard M., Smith S.R., Effect of dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obesity Res., 2004, 12, 1152–1157.
• 9. Grosso L.M., Bracken M.B., Caffeine metabolism, genetics, and perinatal outcomes: A review of exposure assessment considerations during pregnancy. Ann. Epidemiol., 2005, 15, 460––466.
• 10. Gu Y., Hurst W.J., Stuart D.A., Lambert J.D., Inhibition of key digestive enzymes by cocoa extracts and procyanidins. J. Agric. Food Chem., 2011, 59, 5305–5311.
• 11. Haller C.A., Jacob P., Benowitz N.L., Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clin. Pharmacol. Ther., 2004, 75, 259–273.
• 12. Harland B.F., Caffeine and nutrition. Nutrition, 2000, 16, 522––526.
• 13. Mandel H.G., Update on caffeine consumption, disposition and action. Food Chem. Toxicol., 2002, 40, 1231–1234.
• 14. Miled N., Canaan S., Dupuis L., Roussel A., Riviere M., Carriere F., de Caro A., Cambillau C., Verger R., Digestive lipases: From three-dimensional structure to physiology. Biochimie, 2000, 82, 973–986.
• 15. Møller S.E., Larsen F., Pitsiu M., Rolan P.E., Effect of citalopram on plasma levels of oral theophylline. Clin. Ther., 2000, 22, 1494–1501.
• 16. Mun S., Decker E.A., McClements D.J., Infl uence of emulsifi er type on in vitro digestibility of lipid droplets by pancreatic lipase. Food Res. Int., 2007, 40, 770–781.
• 17. Nafi si S., Shamloo D.S., Mohajerani N., Omidi A., A comparative study of caffeine and theophylline binding to Mg(II) and Ca(II) ions: studied by FTIR and UV spectroscopic methods. J. Mol. Struc., 2002, 608, 1–7.
• 18. Näher G., Lipase-titrimetric assay. 1974, in: Methods of Enzymatic Analysis, vol. 2 (ed. H.U. Bergmeyer). Academic Press, pp. 814–818.
• 19. Papaioannou T.G., Karatzi K., Karatzis E., Papamichael C., Lekakis J.P., Acute effects of caffeine on arterial stiffness, wave refl ections, and central aortic pressures. Am. J. Hypertens., 2005, 18, 129–136.
• 20. Ranaldi S., Belle V., Woudstra M., Bourgas R., Guigliarelli B., Roche P., Vezin H., Carriere F., Fournel A., Amplitude of pancreatic lipase lid opening in solution and identifi cation of spin label conformational subensembles by combining continuous wave and pulsed EPR spectroscopy and molecular dynamics. Biochemistry, 2010, 49, 2140–2149.
• 21. Rao F.V., Andersen O.A., Vora K.D., de Martino J.A., van Alten D.M.F., Methylxanthine drugs are chitinase inhibitors: Investigation of inhibition and binding models. Chem. Biol., 2005, 12, 973–980.
• 22. Ruhl C.E., Everhart J.E., Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology, 2005, 128, 24–32.
• 23. Steiner J.M., Williams D.A., Purifi cation of classical pancreatic lipase from dog pancreas. Biochimie, 2002, 84, 1245–1253.
• 24. Sugawara M., Mochizuki T., Takekuma Y., Miyazaki K., Structure-affi nity relationship in the interactions of human organic anion transporter with caffeine, theophylline, theobromine and their metabolites. Biochem. Biophys. Acta, 2005, 1714, 85–92.
• 25. Westerterp-Plantenga M., Diepvens K., Joosen A.M., Berube- Parent S., Tremblay A., Metabolic effects of spices, teas, and caffeine. Physiol. Behav., 2006, 89, 85–91.
• 26. Winkler F.K., D’Arcy A., Hunziker W., Structure of human pancreatic lipase. Nature, 1990, 343, 771–774.
• 27. WHO, World Health Organization International. Evaluation of certain food additives and contaminants. 44th Report of the Join FAO/WHO Expert Committee on Food Additives. WHO Expert Committee on Biological Standardization. 1995, 859, 5–8.

Uwagi

Rekord w opracowaniu